Open AccessEfficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritoneal cancer: study protocol for a phase III, double-blind, randomized study
Author(s) -
Soo Jin Park,
Ga Won Yim,
Haerin Paik,
Nara Lee,
Seungmee Lee,
Maria Lee,
Hee Seung Kim
Publication year - 2021
Publication title -
journal of gynecologic oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.358
H-Index - 37
eISSN - 2005-0399
pISSN - 2005-0380
DOI - 10.3802/jgo.2021.32.e73
Subject(s) - medicine , carboplatin , ovarian cancer , common terminology criteria for adverse events , chemotherapy induced peripheral neuropathy , bevacizumab , clinical endpoint , oncology , chemotherapy , paclitaxel , peripheral neuropathy , adverse effect , fallopian tube cancer , gynecologic oncology , randomized controlled trial , surgery , cancer , cisplatin , endocrinology , diabetes mellitus